The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,

Slides:



Advertisements
Similar presentations
Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
Advertisements

Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Ambulatory Blood Pressure Profiles in Adolescents with Type 1 Diabetes Andrew J. Ellis 1,2, B.A.; David M. Maahs 2, M.D. Ph.D.; Franziska K. Bishop 2,
DAVID C KLONOFF, MD Medical Director Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services Clinical Professor of.
Diabetes Update: Living Life after Lente
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J CLIN ENDOCRINOL METAB, 97, , 2012.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
Effect of Hepatic Impairment on Sorafenib Pharmacokinetics: Results of a Multicenter, Open-Label, Single-Dose, Phase I Trial J Lettieri, A Mazzu,
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Presented by Dr. Soe Sandi Tint
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
Chronic Diabetes Case F Gestational Diabetes Mellitus (GDM) Clinical Pathology B Hoa Nguyen Tuan Anh Tran Thi Thuy Duong Trang.
Closed-Loop Insulin Delivery in Children
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Marta Alves, Celestino Neves, Ana Varela, Cristina Arteiro, Luís Miguel Pereira, Davide Carvalho, José Luís Medina. Endocrinology Service, S. João Hospital,
Precocious “AGE’ing” in Diabetes Precocious “AGE’ing” Effect of Type 1 Diabetes Background T1DM increases formation of advanced glycation end products.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Gestational Diabetes Testing Paradigms in a Rural Office November 7, 2014.
The effects of erythromycin on nutrient absorption in critical illness Dr Gerald Wong FANZCA FCICM Gerald Wong, Anna DiBartolomeo, Marianne Chapman, Matthew.
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
Measurement theory and provider profiling Timothy P. Hofer MD Dept. Medicine, University of Michigan VA Ann Arbor HSR&D Center of Excellence.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
INTRODUCTION The Solution: Point-of-care (POC) continuous glucose sensors offer significant promise for real-time control and artificial pancreas systems.
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Clinical Experience of an Iontophoresis Based Glucose Measuring System
Glucose tolerance testing. A
Protocol for the management of adult patients with DKA
D2d participating clinical sites
Rank-order bar chart of percentage of patient-days with blood glucose results > 299 mg/dl for non-ICU units. Rank-order bar chart of percentage of patient-days.
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Quality Assurance Reference Intervals.
The Research Question Does self monitoring of blood glucose (SMBG) in patients with non-insulin treated type 2 diabetes improve glycemia or quality of.
Protocol for the management of adult patients with HHS
Protocol for the management of adult patients with HHS
Hypoglycemia: The Most Common Barrier to Effective Diabetes Management
Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.
The continuous line represents the sensor glucose values.
(A) Twenty-four-hour plasma profiles of insulin and amylin in healthy subjects. (A) Twenty-four-hour plasma profiles of insulin and amylin in healthy subjects.
Four–time point diurnal profiles of plasma glucose concentrations (A) and AUCs (B) over quintiles of HbA1c. ○, AUC1; •, AUC2; ▴, AUC2 − AUC1 (differences.
Cumulative mean numbers of confirmed (plasma glucose ≤3
Presentation transcript:

The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck, Katrina Ruedy, Andrea Booth, Stuart Weinzimer, and the Diabetes Research in Children Network (DirecNet) Study Group.

Clinical Centers Barbara Davis Center for Childhood Diabetes, Denver, CO Nemours Children’s Clinic, Jacksonville, FL Stanford University Medical Center, Stanford, CA University of Iowa, Iowa City, IA Yale University Medical Center, New Haven, CT Coordinating Center Jaeb Center for Health Research, Tampa, FL

Background Characterization of the diurnal variations in plasma glucose in normal children is critical for the interpretation of glucose values using continuous glucose sensors in pathological states, such as diabetes and hypoglycemic conditions. Preliminary reports and anecdotal data suggest that non-diabetic children have low sensor glucose levels, especially at night (Weinzimer SA, et al, Diabet Technol Ther 2003).

Objective To determine the accuracy of 2 glucose sensors, the Continuous Glucose Monitoring System (CGMS - Medtronics/Minimed) and the Glucowatch® G2TM Biographer (GW2B-Cygnus) in healthy, non diabetic children while examining the 24h pattern of glucose concentrations.

Inclusion Criteria healthy boys and girls ages 7 to 17 years normal HbA1C no first degree relatives with diabetes BMI between 10th and 90th percentile normal Hematocrit no skin abnormalities contraindicating sensor use

Procedures All patients were admitted to each center’s CRC An iv catheter was placed after numbing skin for reference blood glucose determinations every hour during the day (7AM to 9PM) and every 1/2 hour overnight (9:30PM to 6:30AM).

Glucowatch Biographer Measures blood glucose from interstitial fluid via reverse iontophoresis.

CGMS Measures blood glucose via a glucose oxidase based electrochemical sensor. CGMS

GW2B Accuracy Summary Statistics Total 11:00PM-6:00AM 6:30AM -10:30PM Paired data points 487 286 201 Absolute difference (median) 13 13 13 (mg/dl) (25, 75th percentiles) (6,23) (6,24) (7,21) %Values within 10 mg/dl 40% 41% 40% %Values within 20 mg/dl 70% 66% 74%

CGMS Accuracy Summary Statistics Total 11:00PM-6:00AM 6:30AM -10:30PM Paired data points 668 307 361 Absolute difference (median) 17 18 16 (mg/dl) (25, 75th percentiles) (8,29) (8,29) (7,29) %Values within 10 mg/dl 34% 32% 36% %Values within 20 mg/dl 58% 56% 60%

Low glucose readings by sensors GW2B CGMS 108 139 Values <60 mg/dl 7/108 1/139 Isolated readings Coincided with reference glucose 33/108 14/139 Paired value had reference glucose >70 mg/dl 33/33 14/14

Glucose values measured by reference lab, CGMS and GW2B sensors

Glucose values measured by reference lab, CGMS and GW2B sensors

Mean and range serum glucose concentrations (mg/dL) measured by reference lab in healthy children (N=15) Time of Day Glucose (mg/dL)

Summary In healthy non-diabetic children wearing continuous glucose sensors: the median absolute difference in glucose concentrations between the GW2B and reference glucose concentrations is 13 mg/dl, with 40% of values within 10mg/dl of the reference value for CGMS the median absolute difference is 17 mg/dl with 34% of values within 10mg/dl of the laboratory reference.

Conclusions Our data support that: 1) neither the GW2B nor CGMS is accurate enough to provide normative glycemia profiles for non-diabetic children 2) previous reports of low sensor glucose values in non-diabetic children may represent inaccurate glucose measurements 3) serum glucose concentrations in non-diabetic children are tightly controlled.